Modulari-T Bioscience Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
10
Modulari-T Bioscience General Information
Description
Developer of novel antigen receptor architecture and cell therapies designed to overcome the challenges currently faced by CAR-T therapy. The company's modular antigen receptor complexes mimic the modular structure of natural immune receptors where antigen recognition domains and signaling domains are part of different proteins, enabling doctors to address the autoimmune disease by targeting autoreactive immune cells with MARC cells.
Contact Information
Website
www.modularit.bioCorporate Office
- 1250, Rue Guy
- Montreal, Quebec H3H 2T4
- Canada
Corporate Office
- 1250, Rue Guy
- Montreal, Quebec H3H 2T4
- Canada
Modulari-T Bioscience Timeline
Modulari-T Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 01-Jan-2026 | Completed | Pre-Clinical Trials | |||
| 7. Early Stage VC | 03-Apr-2023 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Apr-2022 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 22-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Modulari-T Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Modulari-T Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Modulari-T Bioscience Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Merck Digital Sciences Studio | Accelerator/Incubator | |||
| Pioneer Fund | Venture Capital | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator | |||
| Y Combinator | Accelerator/Incubator | Minority | ||
| MassBio | Accelerator/Incubator |
Modulari-T Bioscience FAQs
-
When was Modulari-T Bioscience founded?
Modulari-T Bioscience was founded in 2021.
-
Where is Modulari-T Bioscience headquartered?
Modulari-T Bioscience is headquartered in Montreal, Canada.
-
What is the size of Modulari-T Bioscience?
Modulari-T Bioscience has 9 total employees.
-
What industry is Modulari-T Bioscience in?
Modulari-T Bioscience’s primary industry is Drug Discovery.
-
Is Modulari-T Bioscience a private or public company?
Modulari-T Bioscience is a Private company.
-
What is Modulari-T Bioscience’s current revenue?
The current revenue for Modulari-T Bioscience is .
-
How much funding has Modulari-T Bioscience raised over time?
Modulari-T Bioscience has raised $500K.
-
Who are Modulari-T Bioscience’s investors?
Merck Digital Sciences Studio, Pioneer Fund, Creative Destruction Lab, Y Combinator, and MassBio are 5 of 10 investors who have invested in Modulari-T Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
